Six top scientists of the Technische Universitaet Muenchen (TUM) have been awarded prestigious ERC Grants: 1.5 million goes to Prof. Stephan A. Sieber for the development of drugs to combat multi-resistant germs; Prof. Hendrik Dietz receives 1.5 million to study interactions between cellular components; 1.6 million goes to Prof. Andrzej Buras, who wants to develop a basic theory on elementary particles; Prof. Daniel Cremers (1.98 million) is working on better algorithms for image processing; Prof. Karl-Ludwig Laugwitz (1.8 million) aims to explain the causes of a hereditary heart disease; and Prof. Eckehard Steinbach (1.5 million) wants to improve data communication for remotely controlled robots.
Drugs for Fighting Multi-Resistant Bacteria
Infectious diseases have experienced a dangerous renaissance in recent years. Multi-resistant germs have emerged from the imprudent administration of antibiotics. Some pathogens, such as the multi-resistant Staphylococcus aureus (MRSA), cannot be fought with existing antibiotics. This has had dramatic consequences for treatment and has lead to a sharp increase in deaths worldwide. A central research goal is thus to develop new and effective therapies against MRSA and other pathogens. The Sieber team has already been able to establish a new agent in this field. It weakens the bacteria in their pathogenicity and virulence, making the disease easier to treat. The ERC grant has now given rise to wholly new perspectives in the identification of additional agents and has opened an investigation into the molecular basis of infectious diseases. The analytics will be a central focus through the help of which new, nature-derived substances can be tested for their potential therapeutic effect against multi-resistant germs. These research results should ultimately lead to more effective therapies and a better understanding of bacterial virulence and its treatment.
Prof. Stephan A. Sieber is Chair of
|Contact: Patrick Regan|
Technische Universitaet Muenchen